Stem cell pioneer James Thomson and two other University of Wisconsin-Madison scientists have started a company that aims to grow platelets and red blood cells from embryonic stem cells.
The company, Stem Cell Products Inc., has the chance to have the first therapeutic product based on human embryonic stem cells to make it to the marketplace, said Bob Palay, managing member of Tactics II Ventures LP, a Wisconsin venture capital firm that invested in and helped start the company.